Hydropothecary has locked down a previously announced bought deal placement, with investors taking an over-allotment option for an extra $20 million in financing.
The full round is worth $150 million and currently stands as the largest public equity deal in Canadian cannabis history – for at least a few days. Smith Falls-based pot producer Canopy Growth expects to close a $200-million round next week.
Hydropothecary (TSX-V:THCX) initially announced it would raise $100 million a few weeks ago, but immediately increased the deal value due to high demand.
(Sponsored)
Unlock your building’s hidden performance – without a major retrofit
When it comes to reducing energy use in commercial buildings, retrofits often take centre stage. But Ottawa building owners are discovering that one of the most cost-effective strategies isn’t new
CHEO Gala: A dazzling night of glitz, glamour and good deeds
With its throwback theme to the Roaring 20s, luxe aesthetic, and 360-degree cocktail hub within the walls of the historic Fairmont Château Laurier, CHEO’s annual gala promises to be an
Chief executive Sébastien St. Louis told OBJ then that the new funding will allow Hydropothecary to tackle the Canadian cannabis market.
The Gatineau company has had an up-and-down week on the TSX Venture Exchange. Shares hit a high of $5.25 a week ago but have dropped below $4 since, a decrease of more than 25 per cent over the past seven days.
